Our plan is to stop the spread of cancer without stopping your life.

Cancer containment therapy is a new approach that aims to disrupt cancer growth without toxic side effects.

Learn More

There are three big, ugly facts about cancer.

  1. 1

    Despite decades of drug development, cancer death rates are largely the same as they were in the 1940s — 25 years before Neil Armstrong walked on the moon.

    Graph: Cancer Mortality Rates in the United States, 1930 - 2010

    Yearly age-adjusted (2000 U.S. standard population) rate of deaths per 100,000 (5-year smoothed) from cancer in men (stomach, colon, liver, pancreas, lung, prostate, leukemia) and women (stomach, colon, pancreas, lung, breast, uterus, liver). Adapted from American Cancer Society, Cancer Facts & Figures 2015.

  2. 2

    Diagram: Effects of Chemotherapy Treatment

    Current therapies like chemo and radiation are so brutal because they create a toxic environment in the body, destroying both healthy cells and cancer cells in order to work.

  3. 3

    And in almost every case, it's not one tumor that kills a person.

    It's the unrelenting spread of cancer cells.

Remedy Plan will develop the first drugs that specifically and effectively stop the spread of cancer, instead of attacking both cancer cells and healthy cells.

Remedy Plan technology allows us to create drugs for use in cancer containment therapy, a new approach to cancer treatment that targets the metastatic properties of cancer cells. More Information

Diagram: Effects of Cancer Containment Therapy

This will change everything about the way we treat cancer.

Imagine if cancer was no longer a lethal disease.

With cancer fully contained, life could just go on.

For cancer patients and their families, that is the most amazing thing imaginable.

How does it work?

Distinction

Cancer cells that spread throughout the body have the ability to migrate, multiply, and morph into other types of cells.

These are not properties that are found in healthy cells.

Detection

Recent scientific breakthroughs show that these qualities are incredibly similar to properties found in embryonic cells, the supercells responsible for growing the human body.

More Information

Demonstration

Building on these breakthroughs, we've invented technology that allows us to measure a cancer cell's ability to spread.

More Information

Development

Remedy Plan technology will be used to develop drugs that target these spreading abilities — abilities that aren't shared by healthy cells.

Now we want to make the drugs.

We are at the preliminary stages of this process, and have seen some very exciting results.

We see the future in this work.

We are a team of PhDs, professors, tech entrepreneurs, and successful cancer drug company veterans who want to tackle the biggest health problem of our time.

Stay Connected With Us

Sign up below to hear more from us, get updates from the field, and to be the first to know about our progress towards a drug candidate.

We'll send you updates every few months, and will never share your information with anyone else.

Frequently Asked Questions

  • What is cancer containment therapy?

    Cancer containment therapy is a new way of treating cancer patients. This treatment involves drugs that disrupt the ability of cancer cells to spread throughout the body. Rather than focusing on annihilating the tumor, this therapy contains the spread of cancerous cells.

  • Wouldn't it be better to eradicate the tumor than to just stop it from spreading?

    There is no safe and effective way to eradicate cancerous tumors. We haven't been able to significantly change the number of people who die from cancer each year no matter how many nasty chemicals or rounds of radiation we've thrown at patient's bodies over the last half century.

    It's time to start thinking about the problem from a different angle. The really horrific parts of this disease are due to the spread of cancerous cells- that's usually what kills people, not the actual original tumor. We can more effectively save lives by stopping the aspect of the tumor that is killing people.

  • What type of cancers will this work on?

    Because we're targeting an aspect of tumors (the ability to metastasize) shared by many types of cancer, our therapies will be applicable to a wide variety of cancer types, including breast cancer and lung cancer.

  • What are the side effects of treatment?

    Cancer containment therapy is non-toxic because it targets an aspect of cancer cells not shared by healthy mature cells. The characteristic that allows cancer to grow and spread is similar to the properties of human stem cells, but is not a property of healthy adults. Thus unlike chemotherapy, cancer containment therapy differentiates between cancer cells and healthy cells. This means that our drugs will not only be more effective, but that patients and their families will no longer have to endure the terrible side effects typical of traditional treatments.

  • How is this different?

    Today, nearly all cancer drugs aim to create a toxic environment around cancer cells – whether it is chemotherapy or radiation destroying a cell’s DNA, starving tumor cells by disrupting blood vessel formation, or unleashing the immune system to attack cancer cells. None of these approaches work well, and they all have terrible, toxic side effects.

    Our approach is different from the many scientists focused on cancer research in multiple ways: First, our new technology provides a better way to distinguish the most dangerous cancer cells from healthy cells. Second, we aren’t developing drugs that are aimed at killing, starving, or destroying cells; our drugs will contain cancer cells and stop them from spreading. And finally, our approach to drug screens, our Remedy Plan technology, and our devoted team of experts mean we are poised to develop the first non-toxic drug that will render cancer cells harmless.

  • I (or my family member or friend) have cancer. Will this help me/them?

    Possibly, but it will be a while before drugs are available. We are still in the early stages of our research, which is why we are crowdfunding our initial drug screens. The time it takes to get from a great idea, through multiple phases of drug screens, past FDA approval, and finally into a drug in a patient's hand can be very long, possibly as long as five to ten years. We are looking for help from people like you to help us get through these drug screens faster. Even so, it could be years before cancer containment therapy is available to you or your family member.

  • What if I am an accredited investor and I want to invest?

    Remedy Plan is going to revolutionize cancer treatment, and we are definitely looking for visionary investors with which to partner. We are offering favorable terms on convertible notes, the well established model for early stage investments. If you are an accredited investor, and you want to hear more about how you can become part of this big idea, email Greg Crimmins for more information ([email protected]).

  • What is your drug screening platform measuring?

    We have engineered a platform that allows us to measure the expression of several fluorescent proteins that are expressed downstream of promoters active only in early, non-differentiated embryonic cells.

  • Do you use human embryonic stem cells in your research?

    No, Remedy Plan does not work with any human embryonic cells.

  • Hasn't the industry moved more toward target based screens?

    Many scientists and companies are starting to move back toward phenotypic screens due to their greater potential for developing new classes of drugs that provide a big leap forward in treatment. Target based screens presume we know the exact right target, which is unfortunately not true for most cutting edge research. Luckily, target identification options have greatly improved, and we are confident we will identify the target and molecular mechanism of the majority of our drug candidates.

  • Are your drugs going to be toxic to adult stem cells?

    No. Embryonic cells and adults stem cells are fundamentally different cells, whose differences far outnumber their similarities. The cellular properties we are inhibiting are only found in the early embryonic cells and in cancer, and are present in no other cell in the adult body. Cancer is in many ways a disease of developmental reversal, of cancer cells going back to an early embryonic state of rapid growth. This is one of the greatest strengths of our approach: the properties we are inhibiting do not exist in any mature cells, including adult stem cells, thus eliminating toxicity of treatments.